KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 0.18%.

  • Evolent Health's EBIT Margin rose 28000.0% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.0%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 1.58% for FY2024, which is 20400.0% up from last year.
  • Evolent Health's EBIT Margin amounted to 0.18% in Q3 2025, which was up 28000.0% from 0.26% recorded in Q2 2025.
  • In the past 5 years, Evolent Health's EBIT Margin ranged from a high of 3.67% in Q3 2022 and a low of 7.41% during Q1 2021
  • Moreover, its 5-year median value for EBIT Margin was 2.42% (2023), whereas its average is 2.06%.
  • Its EBIT Margin has fluctuated over the past 5 years, first surged by 1004700bps in 2021, then tumbled by -71800bps in 2023.
  • Quarter analysis of 5 years shows Evolent Health's EBIT Margin stood at 4.92% in 2021, then skyrocketed by 90bps to 0.49% in 2022, then tumbled by -682bps to 3.84% in 2023, then increased by 25bps to 2.88% in 2024, then surged by 106bps to 0.18% in 2025.
  • Its last three reported values are 0.18% in Q3 2025, 0.26% for Q2 2025, and 0.34% during Q1 2025.